[HTML][HTML] Systematic review of the management of mycotic aortic aneurysms

K Sörelius, J Budtz-Lilly, K Mani… - European Journal of …, 2019 - Elsevier
Objectives The aim of this systematic literature review was to compile an updated overview
of mycotic aortic aneurysm (MAA) treatment and outcomes. Methods A systematic literature …

[HTML][HTML] Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review

CD Kan, HL Lee, YJ Yang - Journal of vascular surgery, 2007 - Elsevier
BACKGROUND: Surgical treatment for mycotic aortic aneurysms is not optimal. Even with a
large excision, extensive debridement, in situ or extra-anatomical reconstruction, and with or …

Endovascular treatment of mycotic aortic aneurysms: a European multicenter study

K Sörelius, K Mani, M Björck, P Sedivy, CM Wahlgren… - Circulation, 2014 - Am Heart Assoc
Background—Mycotic aortic aneurysm (MAA) is a rare and life-threatening disease. The aim
of this European multicenter collaboration was to study the durability of endovascular aortic …

Nationwide study of the treatment of mycotic abdominal aortic aneurysms comparing open and endovascular repair

K Sörelius, A Wanhainen, M Furebring, M Björck… - Circulation, 2016 - Am Heart Assoc
Background: No reliable comparative data exist between open repair (OR) and
endovascular aneurysm repair (EVAR) for mycotic abdominal aortic aneurysms (MAAAs) …

Association of infections and use of fluoroquinolones with the risk of aortic aneurysm or aortic dissection

YH Dong, CH Chang, JL Wang, LC Wu… - JAMA internal …, 2020 - jamanetwork.com
Importance Prior observational studies have suggested that fluoroquinolone use may be
associated with more than 2-fold increased risk of aortic aneurysm or aortic dissection …

[HTML][HTML] Thoracic endovascular aortic repair in management of aortoesophageal fistulas

L Canaud, BA Ozdemir, WW Bee, S Bahia… - Journal of Vascular …, 2014 - Elsevier
Objective To provide a systematic review of the outcomes of thoracic endovascular aortic
repair (TEVAR) for aortoesophageal fistula (AEF) and to identify prognostic factors …

[HTML][HTML] Nationwide study on treatment of mycotic thoracic aortic aneurysms

K Sörelius, A Wanhainen, CM Wahlgren… - European Journal of …, 2019 - Elsevier
Objective Mycotic aortic aneurysms are rare, life threatening, and complex. This nationwide
study aimed to assess outcome after repair of mycotic thoracic aortic aneurysms (MTAAs) …

[HTML][HTML] Mycotic thoracic aortic aneurysm: epidemiology, pathophysiology, diagnosis, and management

L Raavi, P Garg, MWA Hussain, IJ Wadiwala… - Cureus, 2022 - ncbi.nlm.nih.gov
Mycotic thoracic aortic aneurysm (MTAA) is an aneurysm of the aorta caused by infection of
the vessel tissue through microbial inoculation of the diseased aortic endothelium. It is most …

[HTML][HTML] Infected aneurysm of the thoracic aorta

RB Hsu, FY Lin - Journal of vascular surgery, 2008 - Elsevier
BACKGROUND: Infected aneurysm of the thoracic aorta is rare and can be fatal without
surgical treatment. We review our experience with 32 patients during a 12-year period …

Infectious aortitis

EA Foote, RG Postier, RA Greenfield… - Current Treatment Options …, 2005 - Springer
Optional statement Infection of the aorta usually results from septic embolization to the vasa
vasorum, hematogenous seeding of an existing aneurysm, or extension from a contiguous …